2,009
Views
12
CrossRef citations to date
0
Altmetric
Research Article

A comprehensive review on recent nanosystems for enhancing antifungal activity of fenticonazole nitrate from different routes of administration

ORCID Icon, & ORCID Icon
Article: 2179129 | Received 28 Nov 2022, Accepted 06 Feb 2023, Published online: 14 Feb 2023

References

  • Abdelbari MA, El-Mancy SS, Elshafeey AH, Abdelbary AA. (2021). Implementing spanlastics for improving the ocular delivery of clotrimazole: In vitro characterization, ex vivo permeability, microbiological assessment and in vivo safety study. Int J Nanomedicine 16:1–16.
  • Abdelbary AA, Abd-Elsalam WH, Al-Mahallawi AM. (2016). Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment. Int J Pharm 513:688–96.
  • Abdelbary GA, Aburahma MH. (2015). Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain. J Liposome Res 25:107–21.
  • Abdelbary GA, Amin MM, Abdelmoteleb M. (2016). Novel mixed hydrotropic solubilization of Zaleplon: Formulation of oral tablets and in-vivo neuropharmacological characterization by monitoring plasma GABA level. J Drug Delivery Sci Technol 33:98–113.
  • Abdelbary GA, Amin MM, Zakaria MY. (2017). Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv 24:309–19.
  • Abdelgawad R, Nasr M, Moftah NH, Hamza MY. (2017). Phospholipid membrane tubulation using ceramide doping "Cerosomes": Characterization and clinical application in psoriasis treatment. Eur J Pharm Sci 101:258–68.
  • Abdellatif MM, Khalil IA, Khalil MAF. (2017). Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: In-vitro, ex-vivo and in-vivo evaluation. Int J Pharm 527:1–11.
  • Abd-Elsalam WH, ElKasabgy NA. (2019). Mucoadhesive olaminosomes: A novel prolonged release nanocarrier of agomelatine for the treatment of ocular hypertension. Int J Pharm 560:235–45.
  • Abd-Elsalam WH, Ibrahim RR. (2021). Span 80/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections. Int J Pharm 609:121214.
  • Abdulbaqi IM, Darwis Y, Khan NA, et al. (2016). Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine 11:2279–304.
  • Ahmad I, Pandit J, Sultana Y, et al. (2019). Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study. Mater Sci Eng C Mater Biol Appl 100:959–70.
  • Ahmed S, Amin MM, El-Korany SM, Sayed S. (2022). Corneal targeted fenticonazole nitrate-loaded novasomes for the management of ocular candidiasis: Preparation, in vitro characterization, ex vivo and in vivo assessments. Drug Deliv 29:2428–41.
  • Ahmed S, Amin MM, El-Korany SM, Sayed S. (2022). Pronounced capping effect of olaminosomes as nanostructured platforms in ocular candidiasis management. Drug Deliv 29:2945–58.
  • Ahmed S, Amin MM, Sayed S. (2023). Ocular drug delivery: a comprehensive review. AAPS PharmSciTech 24.
  • Ahmed S, Kassem MA, Sayed S. (2020). Bilosomes as promising nanovesicular carriers for improved transdermal delivery: Construction, in vitro optimization, ex vivo permeation and in vivo evaluation. Int J Nanomedicine 15:9783–98.
  • Ahmed S, Kassem MA, Sayed S. (2021). Co-polymer mixed micelles enhanced transdermal transport of Lornoxicam: in vitro characterization, and in vivo assessment of anti-inflammatory effect and antinociceptive activity. J Drug Delivery Sci Technol 62:102365.
  • Alamri MA, Tahir Ul Qamar M, Mirza MU, et al. (2021). Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL(pro). J Biomol Struct Dyn 39:4936–48.
  • Albash R, Al-Mahallawi AM, Hassan M, Alaa-Eldin AA. (2021). Development and optimization of terpene-enriched vesicles (terpesomes) for effective ocular delivery of fenticonazole nitrate: In vitro characterization and in vivo assessment. Int J Nanomedicine 16:609–21.
  • Albash R, Elmahboub Y, Baraka K, et al. (2020). Ultra-deformable liposomes containing terpenes (terpesomes) loaded fenticonazole nitrate for treatment of vaginal candidiasis: Box-Behnken design optimization, comparative ex vivo and in vivo studies. Drug Deliv 27:1514–23.
  • Albash R, El-Nabarawi MA, Refai H, Abdelbary AA. (2019). Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment. Int J Nanomedicine 14:6555–74.
  • Albash R, Ragaie MH, Hassab MAE, et al. (2022). Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: design characterization, in silico study, and exploratory clinical appraisal. Drug Deliv 29:1100–11.
  • Albash R, Yousry C, Al-Mahallawi AM, Alaa-Eldin AA. (2021). Utilization of PEGylated cerosomes for effective topical delivery of fenticonazole nitrate: in-vitro characterization, statistical optimization, and in-vivo assessment. Drug Deliv 28:1–9.
  • Al-Mahallawi AM, Khowessah OM, Shoukri RA. (2014). Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm 472:304–14.
  • Al-Mahallawi AM, Khowessah OM, Shoukri RA. (2017). Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies. Int J Pharm 522:157–64.
  • Aziz DE, Abdelbary AA, Elassasy AI. (2018). Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. Drug Deliv 25:815–26.
  • Bajani D, Gharai D, Dey J. (2018). A comparison of the self-assembly behaviour of sodium N-lauroyl sarcosinate and sodium N-lauroyl glycinate surfactants in aqueous and aqueo-organic media. J Colloid Interface Sci 529:314–24.
  • Caliceti P, Salmaso S, Elvassore N, Bertucco A. (2004). Effective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques. J Control Release 94:195–205.
  • Castro BM, Prieto M, Silva LC. (2014). Ceramide: a simple sphingolipid with unique biophysical properties. Prog Lipid Res 54:53–67.
  • Chaudhari P, Naik R, Sruthi Mallela L, et al. (2022). A supramolecular thermosensitive gel of ketoconazole for ocular applications: In silico, in vitro, and ex vivo studies. Int J Pharm 613:121409.
  • Durukan C, Kiskan B, Yagci Y. (2019). One-pot synthesis of amide-functional main-chain polybenzoxazine precursors. Polymers (Basel) 11:679.
  • Eldeeb Salah EA, Ghorab S. (2019). M. Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: Ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Delivery Sci Technol 52:236–47.
  • El-Laithy HM, Shoukry O, Mahran LG. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77:43–55.
  • El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. (2018). Dapsone-loaded invasomes as a potential treatment of acne: Preparation, characterization, and in vivo skin deposition assay. AAPS PharmSciTech 19:2174–84.
  • El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. (2020). Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay. J Liposome Res 30:1–11.
  • Elsayed I, Sayed S. (2017). Tailored nanostructured platforms for boosting transcorneal permeation: Box-Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization. Int J Nanomedicine 12:7947–62.
  • Emad Eldeeb A, Salah S, Ghorab M. (2019). Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv 26:509–21.
  • Fahmy AM, Hassan M, El-Setouhy DA, et al. (2021). Voriconazole ternary micellar systems for the treatment of ocular mycosis: Statistical optimization and in vivo evaluation. J Pharm Sci 110:2130–8.
  • Faisal W, Soliman GM, Hamdan AM. (2018). Enhanced skin deposition and delivery of voriconazole using ethosomal preparations. J Liposome Res 28:14–21.
  • Goldschmidt P, Degorge S, Che Sarria P, et al. (2012). New strategy for rapid diagnosis and characterization of fungal infections: the example of corneal scrapings. PLoS One 7:e37660.
  • Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:1.
  • Huang J, Peng T, Li Y, et al. (2017). Ocular cubosome drug delivery system for timolol maleate: Preparation, characterization, cytotoxicity, ex vivo, and in vivo evaluation. AAPS PharmSciTech 18:2919–26.
  • Humphries RM, Ambler J, Mitchell SL, et al. (2018). CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. J Clin Microbiol 56:1934.
  • Imam SS, Ahad A, Aqil M, et al. (2017). Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: In-vitro characterization, and in-vivo appraisal. Mater Sci Eng C Mater Biol Appl 75:1198–205.
  • Imanian ME, Biglari FR. (2022). Modeling and prediction of surface roughness and dimensional accuracy in SLS 3D printing of PVA/CB ­composite using the central composite design. J Manuf Processes 75:154–69.
  • Ing LY, Zin NM, Sarwar A, Katas H. (2012). Antifungal activity of chitosan nanoparticles and correlation with their physical properties. Int J Biomater 2012:632698.
  • Javed R, Zia M, Naz S, et al. (2020). Role of capping agents in the application of nanoparticles in biomedicine and environmental remediation: recent trends and future prospects. J Nanobiotechnology 18:172.
  • Ji Y, Yang X, Ji Z, et al. (2020). DFT-calculated IR spectrum amide I, II, and III band contributions of N-methylacetamide fine components. ACS Omega 5:8572–8.
  • Kim Y-I, Kim S-I, Choi J-Y. (1989). Dissolution enhancement of fenticonazole nitrate from hydrophilic polymer solid dispersions. J Pharm Investig 19:109–16.
  • Kumar L, Verma S, Bhardwaj A, et al. (2014). Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review. Artif Cells Nanomed Biotechnol 42:32–46.
  • Li Q, Li Z, Zeng W, et al. (2014). Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci 62:115–23.
  • Lockhart SR, Guarner J. (2019). Emerging and reemerging fungal infections. Semin Diagn Pathol 36:177–81.
  • Manconi M, Mura S, Sinico C, et al. (2009). Development and characterization of liposomes containing glycols as carriers for diclofenac. Colloids Surf, A 342:53–8.
  • Martinez-Perez B, Quintanar-Guerrero D, Tapia-Tapia M, et al. (2018). Controlled-release biodegradable nanoparticles: From preparation to vaginal applications. Eur J Pharm Sci 115:185–95.
  • Mbewana-Ntshanka NG, Moloto MJ, Mubiayi PK. (2020). Role of the amine and phosphine groups in oleylamine and trioctylphosphine in the synthesis of copper chalcogenide nanoparticles. Heliyon 6:e05130.
  • Mishra KK, Kaur CD, Gupta A. (2022). Development of itraconazole loaded ultra-deformable transethosomes containing oleic-acid for effective treatment of dermatophytosis: Box-Behnken design, ex-vivo and in-vivo studies. J Drug Delivery Sci Technol 67:102998.
  • Mohanty B, Mishra SK, Majumdar DK. (2013). Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops. J Adv Pharm Technol Res 4:210–6.
  • Morita SY, Ikeda Y. (2022). Regulation of membrane phospholipid biosynthesis in mammalian cells. Biochem Pharmacol 206:115296.
  • Mosallam S, Ragaie MH, Moftah NH, et al. (2021). Use of novasomes as a vesicular carrier for improving the topical delivery of terconazole: In vitro characterization, in vivo assessment and exploratory clinical experimentation. Int J Nanomedicine 16:119–32.
  • Mosallam S, Sheta NM, Elshafeey AH, Abdelbary AA. (2021). Fabrication of highly deformable bilosomes for enhancing the topical delivery of terconazole: In vitro characterization, microbiological evaluation, and in vivo skin deposition study. AAPS PharmSciTech 22:74.
  • Muller RH, Jacobs C, Kayser O. (2001). Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3–19.
  • Niu M, Tan Y, Guan P, et al. (2014). Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study. Int J Pharm 460:119–30.
  • Rangsimawong W, Opanasopit P, Rojanarata T, Ngawhirunpat T. (2014). Terpene-containing PEGylated liposomes as transdermal carriers of a hydrophilic compound. Biol Pharm Bull 37:1936–43.
  • Safo IA, Dosche C, Ozaslan M. (2019). Effects of capping agents on the oxygen reduction reaction activity and shape stability of Pt nanocubes. Chemphyschem 20:3010–23.
  • Said M, Aboelwafa AA, Elshafeey AH, Elsayed I. (2021). Central composite optimization of ocular mucoadhesive cubosomes for enhanced bioavailability and controlled delivery of voriconazole. J Drug Delivery Sci Technol 61:102075.
  • Sarheed O, Dibi M, Ramesh K. (2020). Studies on the effect of oil and surfactant on the formation of alginate-based O/W lidocaine nanocarriers using nanoemulsion template. Pharmaceutics 12:1223.
  • Sayed S, Abdelmoteleb M, Amin MM, Khowessah OM. (2020). Effect of formulation variables and gamma sterilization on transcorneal permeation and stability of proniosomal gels as ocular platforms for antiglaucomal drug. AAPS PharmSciTech 21:87.
  • Sayed S, Abdel-Moteleb M, Amin MM, Khowessah OM. (2021). Cubogel as potential platform for glaucoma management. Drug Deliv 28:293–305.
  • Sayed S, Habib BA, Elsayed GM. (2018). Tri-block co-polymer nanocarriers for enhancement of oral delivery of felodipine: preparation, in vitro characterization and ex vivo permeation. J Liposome Res 28:182–92.
  • Shukla A, Krause A, Neubert RH. (2003). Microemulsions as colloidal vehicle systems for dermal drug delivery. Part IV: Investigation of microemulsion systems based on a eutectic mixture of lidocaine and prilocaine as the colloidal phase by dynamic light scattering. J Pharm Pharmacol 55:741–8.
  • Singh A, Yadagiri G, Parvez S, et al. (2020). Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate. Mater Sci Eng C Mater Biol Appl 117:111279.
  • Sondi I, Salopek-Sondi B. (2004). Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177–82.
  • Song CK, Balakrishnan P, Shim CK, et al. (2012). A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces 92:299–304.
  • Su R, Yang L, Wang Y, et al. (2017). Formulation, development, and optimization of a novel octyldodecanol-based nanoemulsion for transdermal delivery of ceramide IIIB. Int J Nanomedicine 12:5203–21.
  • Subongkot T, Duangjit S, Rojanarata T, et al. (2012). Ultradeformable liposomes with terpenes for delivery of hydrophilic compound. J Liposome Res 22:254–62.
  • Tagami T, Ernsting MJ, Li SD. (2011). Optimization of a novel and ­improved thermosensitive liposome formulated with DPPC and a ­Brij surfactant using a robust in vitro system. J Control Release 154:290–7.
  • Vega E, Egea MA, Garduno-Ramirez ML, et al. (2013). Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-beta-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy. Colloids Surf B Biointerfaces 110:339–46.
  • Vizcarra-Pacheco M, Ley-Flores M, Matrecitos-Burruel AM, et al. (2021). Synthesis and characterization of a bioconjugate based on oleic acid and L-cysteine. Polymers (Basel) 13:1791.
  • Wong TW, Dhanawat M, Rathbone MJ. (2014). Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development. Expert Opin Drug Deliv 11:1419–34.
  • Yilmaz E, Borchert HH. (2005). Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides. Eur J Pharm Biopharm 60:91–8.
  • Younes NF, Abdel-Halim SA, Elassasy AI. (2018). Corneal targeted Sertaconazole nitrate loaded cubosomes: Preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm 553:386–97.
  • Younes NF, Abdel-Halim SA, Elassasy AI. (2018). Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization. Drug Deliv 25:1706–17.
  • Yousry C, Ahmed IS, Amin MM, El Gazayerly ON. (2019). Superhydrophobic substrates for ultrahigh encapsulation of hydrophilic drug into controlled-release polyelectrolyte complex beads: statistical optimization and in vivo evaluation. Pharmaceutics 11:257.
  • Zhang K, Lv S, Li X, et al. (2013). Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin. Int J Nanomedicine 8:3227–39.